proline has been researched along with Carcinoma, Non-Small Cell Lung in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, L; Wang, X; Yin, W | 1 |
| Cao, Y; Chen, C; Liu, N; Liu, S; Liu, Y; Mao, C; Ouyang, L; Shi, Y; Tang, H; Tao, Y; Wang, M; Wang, X; Xiao, D; Yan, Q | 1 |
| Chang, Q; Li, YL; Zhao, X | 1 |
| Knezevic, CE; Kratz, LE; Marzinke, MA; Ness, MA | 1 |
| Anthwal, S; Arenberg, DA; Keshamouni, VG; Newstead, MJ; Reddy, RC; Standiford, TJ | 1 |
| Ahrendt, SA; Hu, Y; McDermott, MP | 1 |
| Borg, A; Dziadziuszko, R; Jassem, E; Jassem, J; Kobierska-Gulida, G; Limon, J; Rzyman, W; Szymanowska, A | 1 |
| Bindokas, VP; Jagadeeswaran, R; Jagadeeswaran, S; Salgia, R | 1 |
| Andreassen, T; Ekstrøm, PO; Haugen, A; Lind, H; Ryberg, D; Skaug, V; Stangeland, L; Zienolddiny, S | 1 |
| Boldrini, L; Fontanini, G; Gisfredi, S; Greco, G; Lucchi, M; Mussi, A; Ursino, S | 1 |
| Levine, AJ; Walker, KK | 1 |
| Fujisawa, T; Kakisawa, K; Kimura, H; Murata, M; Shirasawa, H; Tagawa, M | 1 |
| Baptiste, N; Chen, X; Friedlander, P; Prives, C | 1 |
13 other study(ies) available for proline and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
PELP1 is overexpressed in lung cancer and promotes tumor cell malignancy and resistance to tyrosine kinase inhibitor drug.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Co-Repressor Proteins; CTLA-4 Antigen; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Glutamates; Humans; Leucine; Lung Neoplasms; Proline; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Transcription Factors | 2022 |
Cancer progression is mediated by proline catabolism in non-small cell lung cancer.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Disease Progression; Humans; Lung Neoplasms; Mice; Proline; Transfection | 2020 |
Total synthesis and cyclization strategy of samoamide A, a cytotoxic cyclic octapeptide rich in proline and phenlalanine isolated from marine cyanobacterium.
Topics: Antineoplastic Agents; Aquatic Organisms; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cyanobacteria; Humans; Lung Neoplasms; Molecular Structure; Peptides, Cyclic; Phenylalanine; Proline | 2019 |
Elevated creatinine in a patient on IVIG-therapy.
Topics: Carcinoma, Non-Small-Cell Lung; Creatinine; Female; Humans; Immunoglobulins, Intravenous; Lung Neoplasms; Middle Aged; Paraneoplastic Syndromes; Proline | 2018 |
PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer.
Topics: Amino Acid Motifs; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Chemokine CXCL1; Chemokine CXCL11; Chemokine CXCL5; Chemokines, CXC; Chemotaxis; Chromans; Culture Media, Conditioned; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Factor VIII; Humans; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Interleukin-8; Ligands; Lung Neoplasms; Mice; Mice, SCID; Microcirculation; Neoplasm Transplantation; Neovascularization, Pathologic; NF-kappa B; Pioglitazone; PPAR gamma; Proline; Thiazolidinediones; Thiocarbamates; Transfection; Troglitazone | 2005 |
The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
Topics: Aged; Alleles; Arginine; Carcinoma, Non-Small-Cell Lung; Codon; Female; Gene Frequency; Genotype; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Mutation; Polymorphism, Genetic; Proline; Regression Analysis; Survival Analysis; Tumor Suppressor Protein p53 | 2005 |
Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
Topics: Adenocarcinoma; Arginine; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Genetic Predisposition to Disease; Genotype; Heterozygote; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Polymorphism, Genetic; Proline; Risk Factors; Tumor Suppressor Protein p53 | 2006 |
Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cells.
Topics: Animals; Antioxidants; Carcinoma, Non-Small-Cell Lung; Cell Division; Cell Line, Tumor; Cell Movement; Cell Survival; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Hydrogen Peroxide; Indoles; Lung Neoplasms; Muridae; Phosphorylation; Piperazines; Proline; Proto-Oncogene Proteins c-met; Reactive Oxygen Species; Signal Transduction; Sulfonamides; Thiocarbamates; Tyrosine | 2007 |
Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
Topics: Aged; Alleles; Arginine; Carcinoma, Non-Small-Cell Lung; Cell Transformation, Neoplastic; Codon; DNA Mutational Analysis; Female; Gene Frequency; Genetic Carrier Screening; Genetic Predisposition to Disease; Genotype; Homozygote; Humans; Lung Neoplasms; Male; Middle Aged; Norway; Polymorphism, Single Nucleotide; Proline; Smoking; Tumor Suppressor Protein p53 | 2007 |
Prognostic impact of p53 Pro72 homozygous genotype in non-small cell lung cancer patients.
Topics: Aged; Aged, 80 and over; Arginine; Carcinoma, Non-Small-Cell Lung; Codon; Female; Gene Frequency; Genes, p53; Genotype; Homozygote; Humans; Lung Neoplasms; Male; Middle Aged; Polymorphism, Genetic; Prognosis; Proline; Survival Rate | 2008 |
Identification of a novel p53 functional domain that is necessary for efficient growth suppression.
Topics: Amino Acid Sequence; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Division; Cell Line; Chickens; DNA Damage; Genes, p53; Haplorhini; Humans; Lung Neoplasms; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; Proline; Rats; Recombinant Proteins; Sequence Deletion; Sequence Homology, Amino Acid; Transcriptional Activation; Transfection; Tumor Suppressor Protein p53 | 1996 |
Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients.
Topics: Adenocarcinoma; Aged; Alleles; Arginine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Codon; Disease Susceptibility; Female; Genes, p53; Genetic Carrier Screening; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Proline; Risk Factors; Smoking | 1998 |
The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.
Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Clone Cells; Colchicine; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Daunorubicin; DNA Damage; DNA, Neoplasm; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Lung Neoplasms; Models, Biological; Proline; Promoter Regions, Genetic; Protein Structure, Tertiary; Recombinant Fusion Proteins; Structure-Activity Relationship; Tetracycline; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |